EurekAlert! Cancer Research

News Releases

Updates every hour. Last Updated: 14-Dec-2025 03:11 ET (14-Dec-2025 08:11 GMT/UTC)

9-Oct-2025

Ochsner Health launches Genetic Wellness Assessment to identify cancer risks early

Ochsner Health System
Business Announcement

The Genetic Wellness Assessment allows individuals to determine whether they may have a higher genetic risk of developing cancer by answering a few simple questions that evaluate individual risk factors. Those identified as having a high risk, or anyone interested in further evaluation, can schedule an appointment to discuss genetic testing. The results of genetic testing are used by healthcare providers to offer personalized recommendations for cancer screening, prevention and further evaluation for patients and family members.

9-Oct-2025

City of Hope Research Spotlight, September 2025

City of Hope
Peer-Reviewed Publication

City of Hope® Research Spotlight offers a glimpse into groundbreaking scientific and clinical discoveries advancing lifesaving cures for patients with cancer, diabetes and other chronic, life-threatening diseases. Each spotlight features research-related news such as recognitions, collaborations and the latest research defining the future of medical treatment.

Journal: Nature Genetics

9-Oct-2025

Lung cancer incidence after September 11, 2001, among World Trade Center responders

JAMA Network
Peer-Reviewed Publication

About The Study: The results of this study of World Trade Center (WTC) responders suggests that, when compared with the lowest reported exposure levels, a higher level of reported exposure to more particulate dust or debris was significantly associated with an increased incidence of lung cancer. Future studies may investigate specific WTC exposures and histologic changes and clarify the role of WTC exposure for prognosis.

Journal: JAMA Network Open

9-Oct-2025

UMass Amherst researchers create nanoparticle vaccine that prevents cancer in mice

University of Massachusetts Amherst
Peer-Reviewed Publication

AMHERST, Mass. — A study led by University of Massachusetts Amherst researchers demonstrates that their nanoparticle-based vaccine can effectively prevent melanoma, pancreatic and triple-negative breast cancer in mice. Not only did up to 88% of the vaccinated mice remain tumor-free (depending on the cancer), but the vaccine reduced—and in some cases completely prevented—the cancer’s spread.

Journal: Cell Reports Medicine
Funder: NIH/National Institutes of Health, NIH/National Cancer Institute

9-Oct-2025

AIM-HI Accelerator Fund announces winners of the 2025 Venture Competition

AIM-HI Accelerator Fund
Grant and Award Announcement

In its mission to accelerate transformative cancer innovations and drive cures forward, the AIM-HI Accelerator Fund is pleased to announce the winners of the 2025 AIM-HI Venture Competition: ResNovas Therapeutics, co-founded by Nobel Laureate Carolyn Bertozzi, Ph.D., Michelle Arkin, Ph.D., CTO Ian Churcher, Ph.D., and CEO Gabriele Sulli, Ph.D.; and Chiara Biosciences, co-founded by National Academy of Inventors Fellow Francis Barany, Ph.D. and CEO Kirsten Flowers, MBA.

9-Oct-2025

It’s never too late for those with cancer to quit smoking

WashU Medicine
Peer-Reviewed Publication

A smoking cessation program developed by WashU Medicine researchers and deployed at Siteman Cancer Center prolongs life for cancer patients, according to a new study. Regardless of their type of cancer or how advanced it was, cancer patients lived nearly a year longer when they quit smoking compared to patients who continued smoking.

Journal: Journal of the National Comprehensive Cancer Network
Funder: NIH/National Cancer Institute, NIH/National Institutes of Health, NIH/National Institutes of Health, NIH/National Institutes of Health, NIH/National Institutes of Health, NIH/National Institutes of Health, U.S. Department of Defense, Alvin J. Siteman Cancer Center Siteman Investment Program

9-Oct-2025

New JNCCN study confirms it’s ‘never too late’ to see survival benefits from quitting smoking—even with late-stage cancer

National Comprehensive Cancer Network
Peer-Reviewed Publication

New research in JNCCN—Journal of the National Comprehensive Cancer Network finds that people with cancer who quit smoking had a much lower risk of dying within two years compared to those who kept smoking. The survival benefit was seen across all cancer types and stages, including stages III and IV.

Journal: Journal of the National Comprehensive Cancer Network

8-Oct-2025

Nurses step up to tackle Australia’s skin cancer crisis

University of South Australia
Peer-Reviewed Publication

Australia needs to be innovative when it comes to skin cancer detection by embracing a nurse-led model that could save thousands of lives in the long run, according to a new paper.

Journal: Collegian Journal of the Royal College of Nursing Australia

8-Oct-2025

Health & Medical Environment & Energy Society & Lifestyle Technology & Space Rural & Agriculture Business & Politics More Tiny surface shapes steer cancer cells, paving the way for better lab tests and safer implants

Griffith University
Peer-Reviewed Publication

Researchers develop method to guide how MDA-MB-231 cancer cells – an invasive breast cancer cell – stuck, spread, and multiplied by tweaking the curves and chemistry of microscopic 're-entrant' structures.

Journal: Advanced Materials Interfaces

8-Oct-2025

Prostate testing may not target those most likely to benefit, warn experts

BMJ Group
Peer-Reviewed Publication

Current prostate specific antigen (PSA) testing “may not effectively target testing to those most likely to benefit, raising concerns about overtesting” warn researchers from the University of Oxford in a study of over 10 million men across England published by The BMJ today.

Journal: The BMJ
Funder: Cancer Research UK